Doughty S E, Ferrier R K, Hillan K J, Jackson D G
Safety of Medicines Department, ZENECA Pharmaceuticals, Macclesfield, Cheshire, England.
Toxicol Pathol. 1995 May-Jun;23(3):256-61. doi: 10.1177/019262339502300303.
Changes in the mRNA and protein expression of renin-secreting cells in the juxtaglomerular apparatus (JGA) were examined in the rat following administration of ZENECA ZD8731, an angiotensin II receptor antagonist. Doses of 0 or 90 mg/kg were administered daily by gavage for 26 wk. JGA hypertrophy was apparent in histological sections. Immunohistochemistry demonstrated an increase in the number of renin-containing cells in both the afferent arterioles and the interlobular arteries. Similarly, renin mRNA expression, demonstrated by in situ hybridization, had extended to more proximal segments of the afferent arterioles and was also present in efferent arterioles and interlobular arteries. In conclusion, JGA hypertrophy occurred as a result of antagonism of the angiotensin II receptor. Associated with JGA hypertrophy was increased expression of both renin and renin mRNA, indicative of stimulated renin synthesis caused by an exaggerated pharmacological response of renin-secreting cells to the loss of feedback inhibition by angiotensin II.
在大鼠中,使用血管紧张素II受体拮抗剂ZENECA ZD8731后,对肾小球旁器(JGA)中肾素分泌细胞的mRNA和蛋白质表达变化进行了检测。通过灌胃每日给予0或90 mg/kg的剂量,持续26周。组织学切片显示JGA肥大明显。免疫组织化学表明,入球小动脉和小叶间动脉中含肾素细胞的数量增加。同样,原位杂交显示肾素mRNA表达已扩展到入球小动脉的更近端节段,并且也存在于出球小动脉和小叶间动脉中。总之,JGA肥大是血管紧张素II受体拮抗作用的结果。与JGA肥大相关的是肾素和肾素mRNA表达增加,这表明肾素分泌细胞对血管紧张素II反馈抑制丧失的过度药理反应导致肾素合成受到刺激。